These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9627739)

  • 21. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus.
    Griesmacher A; Kindhauser M; Andert SE; Schreiner W; Toma C; Knoebl P; Pietschmann P; Prager R; Schnack C; Schernthaner G
    Am J Med; 1995 May; 98(5):469-75. PubMed ID: 7733126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of topography on the cognitive and psychopathological effects of tardive dyskinesia.
    Brown KW; White T
    Am J Psychiatry; 1992 Oct; 149(10):1385-9. PubMed ID: 1356314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of erythrocyte lipids, lipid peroxidation, antioxidants and osmotic fragility in cervical cancer patients.
    Kolanjiappan K; Manoharan S; Kayalvizhi M
    Clin Chim Acta; 2002 Dec; 326(1-2):143-9. PubMed ID: 12417105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB; Caligiuri MP
    J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group.
    Adler LA; Rotrosen J; Edson R; Lavori P; Lohr J; Hitzemann R; Raisch D; Caligiuri M; Tracy K
    Arch Gen Psychiatry; 1999 Sep; 56(9):836-41. PubMed ID: 12892048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin E in the treatment of tardive dyskinesia.
    Elkashef AM; Ruskin PE; Bacher N; Barrett D
    Am J Psychiatry; 1990 Apr; 147(4):505-6. PubMed ID: 1969247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment.
    Thaker GK; Tamminga CA; Alphs LD; Lafferman J; Ferraro TN; Hare TA
    Arch Gen Psychiatry; 1987 Jun; 44(6):522-9. PubMed ID: 3034188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effect of haloperidol and clozapine on plasma homovanillic acid in elderly schizophrenic patients with or without tardive dyskinesia.
    Andia I; Zumarraga M; Zabalo MJ; Bulbena A; Davila R
    Biol Psychiatry; 1998 Jan; 43(1):20-3. PubMed ID: 9442340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative mechanisms and tardive dyskinesia.
    Lohr JB; Kuczenski R; Niculescu AB
    CNS Drugs; 2003; 17(1):47-62. PubMed ID: 12467492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses.
    Sajjad SH
    Int Clin Psychopharmacol; 1998 Jul; 13(4):147-55. PubMed ID: 9727725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial.
    Zhang XY; Zhou DF; Cao LY; Xu CQ; Chen DC; Wu GY
    J Clin Psychopharmacol; 2004 Feb; 24(1):83-6. PubMed ID: 14709952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurochemical studies on tardive dyskinesia. I. Urinary homovanillic acid and plasma prolactin.
    Tripodianakis J; Markianos M; Garelis E
    Biol Psychiatry; 1983 Mar; 18(3):337-45. PubMed ID: 6132625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma lipids are not oxidized during hemodialysis.
    Schettler V; Wieland E; Verwiebe R; Schuff-Werner P; Scheler F; Oellerich M
    Nephron; 1994; 67(1):42-7. PubMed ID: 8052366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free radicals, antioxidant defense systems, and schizophrenia.
    Wu JQ; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():200-6. PubMed ID: 23470289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consumption of vitamin E in coronary circulation in patients with variant angina.
    Miwa K; Igawa A; Nakagawa K; Hirai T; Inoue H
    Cardiovasc Res; 1999 Jan; 41(1):291-8. PubMed ID: 10325977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
    Shriqui CL; Bradwejn J; Annable L; Jones BD
    Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term treatment effects of vitamin E for tardive dyskinesia.
    Adler LA; Edson R; Lavori P; Peselow E; Duncan E; Rosenthal M; Rotrosen J
    Biol Psychiatry; 1998 Jun; 43(12):868-72. PubMed ID: 9627740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients.
    Csernansky JG; Kaplan J; Holman CA; Hollister LE
    Psychopharmacology (Berl); 1983; 81(2):115-8. PubMed ID: 6138793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of chronic ethanol feeding on plasma and liver alpha- and gamma-tocopherol levels in normal and vitamin E-deficient rats. Relationship to lipid peroxidation.
    Sadrzadeh SM; Nanji AA; Meydani M
    Biochem Pharmacol; 1994 Jun; 47(11):2005-10. PubMed ID: 8010985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.